BLLN BillionToOne, Inc.
BillionToOne, Inc. (BLLN) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 100% planned / 0% discretionary
Largest single sale: $2.1M.
Where they traded
Last open-market purchase: November 7, 2025 , by Lynch Thomas P. .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| ten Bosch John Roderick | SVP of Laboratory Operations | Sell 10b5-1 | 1,416 | $106.61 | $151.0K | 23,635 −5.7% of holding | |
| Lynch Thomas P. 4 fills | See Remarks | Sell 10b5-1 | 35,112 | $110.33 | $3.9M | 16,428 −68.1% of holding | |
| Atay Oguzhan 10 fills | Chairman and CEO | Sell 10b5-1 | 30,331 | $99.91 | $3.0M | 159,834 −15.9% of holding | |
| Tsao David 2 fills | Chief Technology Officer | Sell 10b5-1 | 20,000 | $98.77 | $2.0M | 11,000 −64.5% of holding | |
| ten Bosch John Roderick | SVP of Laboratory Operations | Sell 10b5-1 | 1,416 | $97.54 | $138.1K | 25,051 −5.4% of holding | |
| Lynch Thomas P. 13 fills | See Remarks | Sell 10b5-1 | 20,000 | $99.99 | $2.0M | 20,662 −49.2% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.